Dan earned his PhD in cell biology and biochemistry from the University of California, San Diego. He then went on to start his biotech career at Genentech. During this period, he led a group responsible for developing novel cellular and advance microscopy assays to report on drug activity and mechanism of action. Dan then joined Cleave Biosciences, a company newly formed to discover and develop drugs for novel targets in protein homeostasis. As head of biology, he contributed to various aspects of the p97 program from early screening efforts through clinical development. Throughout his scientific career, Dan has authored over 20 publications and two patents. Outside of work Dan enjoys adventuring with this family in the mountains with a focus on trail running and rock climbing. When not outside, he can sometimes be found playing violin with the local community orchestra.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.